Clinical Development

Drug Development Regulatory Affairs Operational Updates Market Potential Product Pipeline Therapeutics Immunology Immunotherapy Nektar Therapeutics Product Candidates Licensing Microbiome Therapies Drug Trials Product Development Gene Therapy Drug Collaboration

5 ARTICLES

last mo.

FDA Advisers Find Replimune’s RP1 Trial Results Clinically Meaningful

The panel’s vote strengthens the case for accelerated approval by spotlighting an efficacy signal in a hard‑to‑treat group despite lingering agency doubts about the study’s reliability.

3 ARTICLES

4mo ago

Design Therapeutics Reports Early DT-216P2 Data in Friedreich’s Ataxia

6 ARTICLES

4mo ago

Cellular Intelligence Takes Global Rights to Novo Nordisk’s Parkinson’s Cell Therapy

10 ARTICLES

10mo ago

Enlivex Raises $212 Million to Build RAIN Token Treasury, Plans Matteo Renzi Board Appointment

3 ARTICLES

11mo ago

OS Therapies Posts Significant 2-Year Survival Gain for OST-HER2 in Metastatic Osteosarcoma

4 ARTICLES

this yr.

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

3 ARTICLES

this yr.

Eupraxia Selects 8 mg Dose After Strong EoE Signals, Expands Phase 2b Trial